Patents by Inventor Liming Wang

Liming Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8715932
    Abstract: Nucleic acid sequencing using concatemers of DNA is provided. Optionally, amplified reaction products from the repeated incorporation and excision of a nucleoside complementary to a nucleoside of the DNA to be sequenced onto primer molecules hybridized to the concatemers of DNA are detected. Nucleic acid sequencing using concatemers of DNA and non-natural oligonucleotides is also provided. Nucleic acid sequencing reactions are detected electronically and or optically using arrays of detectors.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: May 6, 2014
    Assignee: Intel Corporation
    Inventors: Xing Su, Kai Wu, Liming Wang, Jianquan Liu, Grace M. Credo
  • Patent number: 8708574
    Abstract: The present invention relates to a field of optical fiber communication. A safeguard device for a fiber adapter used to connect an input optical fiber connector with an output optical fiber connector is provided. In a preferred embodiment, the safeguard device comprises a shutter and a shutter locking unit. The shutter is operably provided at an interface of said fiber adapter to allow the interface to switch between an open position and a closed position, wherein, the shutter at least shuts off the optical beam emitted from the input optical connector when in said closed position. The shutter locking unit is adapted for selectively locking the shutter in the open position or in the closed position.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: April 29, 2014
    Assignee: Tyco Electronics (Shanghai) Co., Ltd.
    Inventors: Jerry Wang, Liming Wang, Peter Bos
  • Patent number: 8703797
    Abstract: The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R3 are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases; systemic vascular barrier related diseases; allergies and other inflammatory diseases; cardiac diseases or conditions; fibrosis; pain and wounds.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: April 22, 2014
    Assignee: Allergan, Inc.
    Inventors: Wenkui K. Fang, Evelyn G. Corpuz, Wha-Bin Im, Ken Chow, Liming Wang
  • Patent number: 8697733
    Abstract: The present invention relates to novel pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: April 15, 2014
    Assignee: Allergan, Inc.
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im
  • Publication number: 20140083456
    Abstract: Disclosed herein are methods and apparatuses for cleaning at least one edge of a substrate. Exemplary methods and apparatuses include a cleaning system comprising (a) a plurality of fluid channels, (b) a plurality of brushes, (c) at least one nozzle, and (d) at least one vibration generator. The brushes may comprise a plurality of bristles and/or nodules and may be connected to at least one of the fluid channels such that fluid flows through the bristles and/or nodules to the substrate edge. At least one vibration generator may be connected to the cleaning system and configured to deliver sonic energy to the plurality of brushes.
    Type: Application
    Filed: September 26, 2012
    Publication date: March 27, 2014
    Applicant: Corning Incorporated
    Inventors: Mitchell Jerome Ramsey, Siva Venkatachalam, Liming Wang
  • Publication number: 20140065376
    Abstract: Methods of shaping a glass sheet each include a step of removing a first portion of the glass sheet to form a first beveled surface. The methods further include the step of removing a second portion of the glass sheet to form a second beveled surface. The methods still further include the step of removing a third portion of the glass sheet comprising a remainder of an end surface of an edge portion of the glass sheet. In further examples, glass sheets are also provided with a first bevel surface intersecting a first glass-sheet surface and an apex surface, and a second bevel surface intersecting a second glass-sheet surface and the apex surface. The glass sheet exhibits a probability of failure of less than 5% at an edge stress of 135 MPa.
    Type: Application
    Filed: August 30, 2012
    Publication date: March 6, 2014
    Inventors: Siva Venkatachalam, Liming Wang
  • Publication number: 20140057958
    Abstract: The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: November 4, 2013
    Publication date: February 27, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Mohammed I. DIBAS, Daniel W. GIL, Ken Chow, Liming WANG, Michael E. GARST, John E. DONELLO
  • Publication number: 20140057878
    Abstract: The present invention relates to novel oxime derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: November 1, 2013
    Publication date: February 27, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, WhaBin Im
  • Publication number: 20140057952
    Abstract: The present invention relates to novel oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 27, 2014
    Applicant: ALLERGAN, INC.
    Inventors: WENKUI K. FANG, Liming Wang, Evelyn G. Corpuz, Ken Chow, WhaBin Im
  • Patent number: 8657504
    Abstract: The present invention discloses an optical fiber connection device, comprising: a base plate; at least one adapter for receiving optical fiber connectors; a rotating and fixing mechanism being provided on the base plate and being connected with the adapters, the rotating and fixing mechanism comprising: a fixing portion for fixedly connecting with the adapter; and a rotating portion being rotatably connected to the base plate, through which the mechanism can rotate between an operation position and a receiving/releasing position; and a positioning member for stably holding the rotating and fixing mechanism in the operation position or the receiving/releasing position, and limiting the rotation angle of the mechanism and that of the adapter within a predetermined angle range.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: February 25, 2014
    Assignee: Tyco Electronics (Shanghai) Co. Ltd.
    Inventors: Buck Wang, Liming Wang
  • Patent number: 8653123
    Abstract: The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl) -2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: February 18, 2014
    Assignee: Allergan, Inc.
    Inventors: Mohammad I. Dibas, Daniel W. Gil, Ken Chow, Liming Wang, Michael E. Garst, John E. Donello
  • Patent number: 8623856
    Abstract: The present invention relates to novel phenoxy-azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: January 7, 2014
    Assignee: Allergan, Inc.
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im
  • Patent number: 8618139
    Abstract: The present invention relates to novel oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: December 31, 2013
    Assignee: Allergan, Inc.
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha Bin Im
  • Publication number: 20130338195
    Abstract: The present invention relates to novel pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: June 20, 2013
    Publication date: December 19, 2013
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im
  • Patent number: 8609636
    Abstract: The present invention relates to novel oxime derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: December 17, 2013
    Assignee: Allergan, Inc.
    Inventors: Wenkui K. Fang, Liming Wang, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im
  • Publication number: 20130324571
    Abstract: The present invention relates to novel N-(imidazolidin-2-ylidene)-heterocyclo penta[b]pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: July 18, 2013
    Publication date: December 5, 2013
    Inventors: Santosh C. Sinha, Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst
  • Publication number: 20130310360
    Abstract: The present invention relates to novel oxime azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: July 23, 2013
    Publication date: November 21, 2013
    Applicant: Allergan, Inc.
    Inventors: Wenkui K. Fang, Liming Wang, Ken Chow, Evelyn G. Corpuz, Wha-Bin Im
  • Patent number: 8586188
    Abstract: A protective paper or film and a method of protecting a glass substrate by applying the protective paper or film having a slip agent composition onto a surface of a glass substrate. The slip agent composition comprises at least one fatty alcohol as defined herein.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: November 19, 2013
    Assignee: Corning Incorporated
    Inventors: Hongkyu Kim, James Robert Matthews, Wanda Janina Walczak, Liming Wang, Ruchirej Yongsunthon
  • Publication number: 20130303577
    Abstract: The present invention relates to novel oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: June 26, 2013
    Publication date: November 14, 2013
    Inventors: Wenkui K. Fang, Evelyn G. Corpuz, Wha-Bin Im, Ken Chow, Liming Wang
  • Publication number: 20130303513
    Abstract: The present invention relates to novel azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    Type: Application
    Filed: June 28, 2013
    Publication date: November 14, 2013
    Applicant: Allergan, Inc.
    Inventors: Wenkui K. Fang, Evelyn G. Corpuz, Wha-Bin Im, Ken Chow, Liming Wang